Recombinant antibody production has explored significant prominence in the biopharmaceutical industry due to its ability to generate large quantities of highly specific and efficacious antibodies for therapeutic applications. Chinese hamster ovary (CHO) cells have identified as a leading platform for high-level recombinant antibody production, owin